Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
1.280
+0.030 (2.40%)
Aug 29, 2025, 4:00 PM - Market closed
Ovid Therapeutics Employees
Ovid Therapeutics had 23 employees as of December 31, 2024. The number of employees decreased by 17 or -42.50% compared to the previous year.
Employees
23
Change (1Y)
-17
Growth (1Y)
-42.50%
Revenue / Employee
$289,174
Profits / Employee
-$1,631,174
Market Cap
91.02M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 23 | -17 | -42.50% |
Dec 31, 2023 | 40 | -4 | -9.09% |
Dec 31, 2022 | 44 | -13 | -22.81% |
Dec 31, 2021 | 57 | -10 | -14.93% |
Dec 31, 2020 | 67 | 8 | 13.56% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
OVID News
- 19 days ago - Ovid Therapeutics Reports Business Updates and Second Quarter 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - Ovid Therapeutics to Participate in the BTIG Virtual Biotech Conference - GlobeNewsWire
- 2 months ago - Ovid Therapeutics Enters Agreement with Immedica Pharma AB for Sale of Future Ganaxolone Royalties - GlobeNewsWire
- 3 months ago - Ovid Therapeutics Reports Business Updates and First Quarter 2025 Financial Results - GlobeNewsWire
- 6 months ago - Ovid Therapeutics Reports Business Updates and Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 6 months ago - Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos to Board of Directors - GlobeNewsWire
- 6 months ago - Ovid Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference - GlobeNewsWire
- 7 months ago - Ovid Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - GlobeNewsWire